Skip to main content
Advertisement
  • Loading metrics

Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey

Abstract

Background

The structural environment of urban slums, including physical, demographic, and socioeconomic attributes, renders inhabitants more vulnerable to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Yet, little is known about the specific determinants that contribute to high transmission within these communities. We therefore aimed to investigate SARS-CoV-2 seroprevalence in an urban slum in Brazil.

Methods and findings

We performed a cross-sectional serosurvey of an established cohort of 2,041 urban slum residents from the city of Salvador, Brazil between November 2020 and February 2021, following the first Coronavirus Disease 2019 (COVID-19) pandemic wave in the country and during the onset of the second wave. The median age in this population was 29 years (interquartile range [IQR] 16 to 44); most participants reported their ethnicity as Black (51.5%) or Brown (41.7%), and 58.5% were female. The median size of participating households was 3 (IQR 2 to 4), with a median daily per capita income of 2.32 (IQR 0.33–5.15) US Dollars.

The main outcome measure was presence of IgG against the SARS-CoV-2 spike protein. We implemented multilevel models with random intercepts for each household to estimate seroprevalence and associated risk factors, adjusting for the sensitivity and specificity of the assay, and the age and gender distribution of our study population. We identified high seroprevalence (47.9%, 95% confidence interval [CI] 44.2% to 52.1%), particularly among female residents (50.3% [95% CI 46.3% to 54.8%] versus 44.6% [95% CI 40.1% to 49.4%] among male residents, p < 0.01) and among children (54.4% [95% CI 49.6% to 59.3%] versus 45.4% [95% CI 41.5% to 49.7%] among adults, p < 0.01). Adults residing in households with children were more likely to be seropositive (48.6% [95% CI 44.8% to 52.3%] versus 40.7% [95% CI 37.2% to 44.3%], p < 0.01). Women who were unemployed and living below the poverty threshold (daily per capita household income <$1.25) were more likely to be seropositive compared to men with the same employment and income status (53.9% [95% CI 47.0% to 60.6%] versus 32.9% [95% CI 23.2% to 44.3%], p < 0.01). Participation in the study was voluntary, which may limit the generalizability of our findings.

Conclusions

Prior to the peak of the second wave of the COVID-19 pandemic, cumulative incidence as assessed by serology approached 50% in a Brazilian urban slum population. In contrast to observations from industrialized countries, SARS-CoV-2 incidence was highest among children, as well as women living in extreme poverty. These findings emphasize the need for targeted interventions that provide safe environments for children and mitigate the structural risks posed by crowding and poverty for the most vulnerable residents of urban slum communities.

Author summary

Why was this study done?

  • Inhabitants of informal settlements or urban slums are at increased risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection during the ongoing pandemic, yet there is limited evidence on the heterogeneities in risk experienced by populations in these high-transmission settings.
  • Understanding the factors that influence risk within slum populations can inform public health prevention strategies in marginalized and under-resourced communities.
  • We wanted to identify sociodemographic factors, such as age and gender, that influence SARS-CoV-2 infection risk among residents of urban slum communities.

What did the researchers do and find?

  • We collected sociodemographic data and measured levels of SARS-CoV-2 anti-S IgG in serum samples from 2,041 urban slum residents from Salvador, Brazil after the first pandemic wave, from November 2020 to February 2021.
  • Overall, 48% of residents had positive antibody levels, reflecting prior SARS-CoV-2 infection.
  • We found that women and children were more likely to have experienced a SARS-CoV-2 infection.

What do these findings mean?

  • Residents of this urban slum community experienced a high risk of SARS-CoV-2 infection during the initial wave of the epidemic in Brazil.
  • Even within the high-risk environment of urban slums, there are superimposed gradients of risk that make women and children particularly vulnerable to Coronavirus Disease 2019 (COVID-19).

Introduction

More than 1 billion people who reside in urban slums or informal settlements are at increased risk of Coronavirus Disease 2019 (COVID-19) and also most likely to suffer loss of employment and income due to disease control measures such as lockdowns [1,2]. Although several studies have demonstrated an association of socioeconomic deprivation with increased COVID-19 risk and mortality, such studies have generally relied on ecological designs or have compared poor communities to wealthier ones [3,4]. Moreover, studies relying on passive reporting of cases may suffer from surveillance bias. Prior studies of transmissible and non-transmissible diseases have shown variations in risk not only between communities but also within socially deprived environments, where certain segments of the population may be particularly vulnerable [5,6]. Yet, there remains little known about the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) risk gradients within urban slum communities and how these risk gradients may inform targeted interventions for this vulnerable population. Although the conditions and structure of each slum community are unique, there may be valuable common insights: regardless of geography, slums are invariably densely populated, have poor infrastructure, lack of access to services, and are inhabited by residents who experience significant housing and financial insecurity.

Brazil is among the countries that have suffered the highest burden of COVID-19, with nearly 680,000 deaths reported as of August 2022 among its 210 million inhabitants over the course of several epidemic waves, the first of which occurred between May and September 2020 [7]. Brazil also has roughly 28 million people—15% of its urban population—residing in slum settlements within cities [1]. Prior to the pandemic, we had been performing long-term longitudinal follow-up of a cohort from the city of Salvador, Brazil to characterize the transmission dynamics and burden of leptospirosis [8], dengue [9], chikungunya [10], and Zika [11] among urban slum residents. Herein, we describe the findings of a serological survey of this cohort conducted after the first epidemic wave in Brazil in 2020, which aimed to examine the socioeconomic and structural factors associated with SARS-CoV-2 infection in the urban slum setting and characterize the gradients of risk within these deprived communities.

Methods

Study site and population

Our study was conducted in the Pau da Lima community in Salvador, Brazil. Geographically, Pau da Lima consists of hills and valleys, with a population of approximately 25,000 inhabitants per the most recent national census [12]. The study site, shown in Fig 1A–1C, encompasses 4 valleys, covering a densely populated area of 0.35 km2. Approximately half of the households do not hold legal titles to their homes, and more than 70% of the heads of household earn less than the Brazilian minimum wage [13]. Since 2002, a collaborative research team has maintained a longitudinal open cohort of residents in this community, which has been previously described [8,9,11,14,15]. Study teams canvas households located within the study area and perform a census (number of residents, age, and gender of residents) in households where at least 1 adult resident is present at the time of the study visit and is able to provide such information. Individuals who meet eligibility criteria (sleeping 3 nights or more per week within the study area, aged 2 years or more) and who provide written informed consent (parental consent for minors <18 years of age) are recruited for participation in household and serological surveys, which have been conducted annually or semiannually since 2002. The most recent serosurvey prior to the COVID-19 pandemic was conducted from September to November 2019 (Fig 1D). For the present study, we conducted a household census as described above and recruited a cross-sectional panel of participants to measure SARS-CoV-2 seropositivity (details in S1 Appendix, “Study recruitment”). Individuals who consented to participate had a similar age distribution, but a higher proportion of female participants compared to individuals who declined (Table A in S1 Appendix).

thumbnail
Fig 1. Study population and context.

Panel (A) shows an aerial image of the study area, with insets depicting the location of the study area within Brazil and Salvador. Panel (B) depicts the location of participating households. The choropleth reflects the spatial distribution of seropositivity within the study area. Panel (C) is a representative photo of the study area. (D) Confirmed cases of COVID-19 in Salvador, Brazil, up to October 2021 (blue). Overlaid over the epidemiologic curve, in purple, are the normalized OD values of serological samples collected from cohort participants prior to the pandemic (September 11 to November 24, 2019) and after the first wave of the pandemic (November 17, 2020 to February 26, 2021). The map in panel (A) was created using ArcGIS software by ESRI. Source: ESRI, Maxar, GeoEye, Earthstar Geographics, CNES/Airbus DS, USDA, USGS, AeroGRID, IGN, HERE, Garmin, OpenStreetMap contributors, and the GIS User Community. Base layers: https://services.arcgisonline.com/ArcGIS/rest/services/World_Imagery/MapServer, https://services.arcgisonline.com/arcgis/rest/services/Canvas/World_Dark_Gray_Base/MapServer. COVID-19, Coronavirus Disease 2019; OD, optical density.

https://doi.org/10.1371/journal.pmed.1004093.g001

Data collection

Surveys and serum samples were collected between November 18, 2020 and February 26, 2021, after the first epidemic wave and in the beginning of the second wave (Fig 1D). The study period preceded the rollout of vaccines to the general population in February 2021, such that the presence of SARS-CoV-2 antibodies was reflective of prior infection. A community field research team conducted a census of each household, listing the number of residents, gender, and number of people per room. The head of household contributed information on the income of each wage-earning resident in the household. Household income per capita was estimated as the total income of all residents divided by the number of residents in each household. Participants who consented also completed a detailed individual-level survey, including data on COVID-19 exposures, COVID-19 cases in the household, preventive behaviors (e.g., handwashing, mask use), medical history, and symptom history. The survey includes participant-reported socioeconomic variables such as type of employment (formal versus informal), race/ethnicity, and level of education. Survey data were recorded and managed using REDCap software hosted at the Instituto Gonçalo Moniz (Fiocruz Bahia) [16]. Blood samples were collected by venipuncture from consenting participants and stored in a cooler for transport to the laboratory facility. After centrifugation, the obtained sera were aliquoted and maintained at −20°C until analysis.

Laboratory methods

We measured levels of immunoglobulin G against the SARS-CoV-2 spike protein (anti-S IgG) in serum samples collected from all cohort participants after the first epidemic wave and in stored serum samples collected during a prior survey before the introduction of SARS-CoV-2 in Brazil. Anti-S IgG levels were measured using a commercially available ELISA kit (Euroimmun AG, Lübeck, Germany), which has a sensitivity of 91.1% (95% CI 80.7% to 96.1%) and specificity of 100% (95% CI 96.5% to 100%) [17]. Following the manufacturer’s recommendations, samples were diluted 1:100 in sample buffer, and a set of calibrator, positive, and negative control samples were included on each plate. Optical density (OD) was measured at a wavelength of 450 nm, and normalized values were derived by dividing the OD value of each test sample by the value of the calibrator. All samples with a normalized OD ≥ 0.8 were defined as positive, based on an estimation of optimal cutoffs (Fig B in S1 Appendix) using a previously described Bayesian mixture model [18]. We consider a higher cutoff (normalized OD ≥ 1.1) in sensitivity analyses.

Data analysis

Initial analyses were planned in February 2021, after completion of data collection. The primary outcome was SARS-CoV-2 seropositivity as assessed by anti-S IgG. We visualized the relationship between age and seroprevalence using a generalized additive model considering age as a continuous variable. We adapted a previously described multilevel Bayesian logistic model incorporating household-level clustering [19] to derive estimates of seroprevalence that are adjusted for the sensitivity and specificity of the assay and the age and gender distribution of our study population. Independent variables in regression models included demographic, socioeconomic, and household variables as assessed from the household and individual surveys. We assessed measures of association using univariable logistic regression. Variables with a statistically significant (p < 0.05) association with SARS-CoV-2 seropositivity in a multivariable logistic regression model were retained in our final models.

As our initial descriptive analyses revealed higher seroprevalence among participants aged <18 years compared to adults, and among female participants, we conducted additional analyses with stratification by age and gender, as well as household composition, employment, and income, to elucidate the underlying factors. We performed a multilevel, multivariable logistic regression that incorporated a random intercept at the household level to estimate the effects of age on SARS-CoV-2 seropositivity in our study population. In addition to the main analysis comparing children to adults, we conducted preplanned analyses further categorizing participants <13 and 13 to 17 years of age. To elucidate whether children contribute to higher transmission, we estimated the effect of presence of children in the household on SARS-CoV-2 seropositivity among adults. We assessed model fit based on Akaike information criterion (AIC) to select the most parsimonious explanatory model.

We hypothesized that the effect of presence of children may be mediated by household size, and we estimated this indirect effect using mediation models. We fitted a Poisson model to predict number of residents per household and a binomial model for seropositivity, incorporating age, gender, and household clustering. We estimated the direct and indirect effects and bootstrap confidence intervals using the R “mediation” package [20]. We explored associations between gender and sociodemographic characteristics (income, employment) that are potential confounders of the observed association between gender and SARS-CoV-2 seropositivity.

Participants with missing values for independent variables were excluded from the relevant analyses (pairwise deletion). There were no missing values for the variables included in our final regression models. We conducted sensitivity analyses using data from households in which we obtained sera from all participants, to assess the robustness of our findings to missing serology data. We conducted a final set of analyses to derive seroprevalence estimates adjusted for assay performance. We applied post-stratification of age- and gender-specific estimates to compare seroprevalence estimates between study participants and residents who declined participation.

All analyses were conducted using the software R, version 4.1.3 [21]. Analysis code is available at: https://github.com/m-fofana/SalvadorSARSCoV2. This study is reported as per the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines (S1 STROBE Checklist).

Ethical considerations

The study was approved by the Institutional Review Boards of the Instituto Gonçalo Moniz, Oswaldo Cruz Foundation (Fiocruz) and the Brazilian National Commission for Ethics in Research (CAAE 35405320.0.1001.5030 and 17963519.0.0000.0040), and the Yale University Human Research Protection Program (2000031554).

Results

Population demographics

A total of 2,041 individuals (1,460 adults and 581 children) in 951 households were recruited among 2,681 eligible residents (Fig A in S1 Appendix). Similar to previous surveys, we observed higher participation among female residents. In 431 households, we obtained serological samples from every resident of the households (979 individuals). Table 1 describes the demographic and socioeconomic characteristics of the study population. The median age was 29 years (interquartile range [IQR] 16 to 44) and 58.5% were female. The median size of participating households was 3 (IQR 2 to 4), with a median household daily per capita income of 2.32 (IQR 0.33 to 5.15) US Dollars (USD). Most participants reported their ethnicity as Black (51.5%) or Brown (41.7%). Overall, 35.2% (503/1,431) of adult participants had 6 or fewer years of formal education, and 51.4% (751/1,460) were unemployed. Most participants reported frequent (every day or most days) adherence to non-pharmaceutical interventions such as handwashing (70.5%), alcohol-based hand sanitizer use (67.0%), and face mask use (72.4%); in contrast, fewer participants reported frequent isolation (43.4%) or physical distancing of ≥2 meters in public spaces (46.6%).

thumbnail
Table 1. Study population and demographic characteristics.

https://doi.org/10.1371/journal.pmed.1004093.t001

Seroprevalence

Fig 1D shows the serology assay results for the cohort, overlaid on the epidemic curve of confirmed COVID-19 cases in Salvador, Brazil. Among 195 samples that were selected and tested from the pre-pandemic survey (from September 9 to November 11, 2019), 2 (1.0%) were positive. Fitting the observed anti-S IgG levels with a Bayesian mixture model revealed little overlap between the predicted distributions of OD values for individuals with and without a serological response (Fig B in S1 Appendix). Based on this model, a cutoff of 0.8 has greater than 95% specificity in identifying serological response (Table B in S1 Appendix).

Of the 2,041 samples collected from November 2020 to February 2021, a total of 982 (48.1%, 95% confidence interval [CI] 45.9% to 50.3%) had positive IgG levels against SARS-CoV-2. The estimated seroprevalence adjusted for household-level clustering and test characteristics was 47.9% (95% CI 44.2% to 52.1%) among study participants. The seroprevalence among all eligible residents, as estimated by post-stratification, was 47.7% (95% CI 44.0% to 51.8%) (Table C in S1 Appendix). Among the 982 seropositive individuals, 327 (33.3% [95% CI 30.4% to 36.4%]) reported having at least 1 COVID-19 related symptom (cough, coryza, sore throat, nasal congestion, shortness of breath, fever, chills, anosmia, dysgeusia, myalgia, arthralgia, nausea, vomiting, diarrhea, or headache) since the beginning of the pandemic. The frequency of reported symptoms was lower among seronegative individuals (24.5% [95% CI 21.9% to 27.2%], difference 8.8% [95% CI 4.8% to 12.9%]). The proportion of households with at least 1 seropositive individual was 56.2%. Of the 179 participants who reported known contact with a COVID-19 case within their household, only 1 reported a case resulting in death.

Risk factors

Estimates of seroprevalence adjusted for test characteristics and household-level clustering were significantly higher among children (54.4% [95% CI 49.6% to 59.3%) than adults (45.4% [95% CI 41.5% to 49.7%], p < 0.01) and in female (50.3% [95% CI 46.3% to 54.8%]) compared to male (44.6% [95% CI 40.1% to 49.4%], p < 0.01) participants (Table 1, Table C in S1 Appendix, and Fig 2A and 2B). Additional variables associated with seropositivity in univariable analyses included low per capita household income and number of residents per household. We did not observe a significant association with race (Table 1 and Table D in S1 Appendix). Reported adherence to non-pharmaceutical interventions was not significantly associated with the risk of seropositivity (Table E in S1 Appendix). Because risk factors (including structural environment of the home, health attitudes, and preventive behaviors) are likely to be correlated among members of a household, we further conducted an analysis using a multilevel multivariable model to account for household-level clustering of risk.

thumbnail
Fig 2. Seroprevalence among children and in their households.

(A) Age distribution of SARS-CoV-2 seronegative (median 32 years, IQR 19–46) and seropositive (median 25 years, IQR 15–41) individuals. (B) SARS-CoV-2 seroprevalence and 95% CI associated with age, as estimated with a generalized additive model. (C) Distribution of household size by age among SARS-CoV-2 seronegative and seropositive individuals. Seropositive individuals tended to be in larger households compared to seronegative individuals in the same age group. (D) Seroprevalence and 95% CI stratified by age group and presence of children in the household. (E) Variation in seroprevalence among children by household composition (number of children and number of adults). The number of other children in the household was associated with higher seroprevalence, but there was no statistically significant difference between households with 1 adult and those with 2 adults. Asterisks indicate statistically significant differences (2-tailed t test, Bonferroni-adjusted p < 0.05: *; <0.01: **; <0.001: ***; α = 0.01, 0.0125, 0.0167 in panels (C–E). CI, confidence interval; IQR, interquartile range; SARS-CoV-2, Severe Acute Respiratory Syndrome Coronavirus 2.

https://doi.org/10.1371/journal.pmed.1004093.g002

Household composition

Household size was larger among seropositive individuals (median 4 (IQR 3 to 5) versus 3 (IQR 2 to 4)) (Fig 2C), and women were more likely to be the sole adults in households with multiple children (Fig C in S1 Appendix). Adults residing in households with children were more likely to be seropositive (48.6% [95% CI 44.8% to 52.3%] versus 40.7% [95% CI 37.2% to 44.3%], p < 0.01). The effect of the presence of children was more prominent among adults aged 30 to 44 years and those aged 60 years or more (Fig 2D). Children were also more likely to be seropositive if they lived with other children, but there was no significant difference in seroprevalence between children who lived with 1 adult and those who lived with 2 adults (56.7% [95% CI 49.1% to 64.0%] versus 53.2% [95% CI 47.0% to 59.4%], p = 0.54, Fig 2E). After adjusting for household clustering, gender, and total number of residents in the household, the OR for SARS-CoV-2 seropositivity among children compared to adults aged 30 to 44 was 2.07 [95% CI 1.42 to 3.03] (Table 2, Model 1).

thumbnail
Table 2. Effect (odds ratio) of age and presence of children in the household.

https://doi.org/10.1371/journal.pmed.1004093.t002

To examine whether the higher seroprevalence observed among adults living with children was mediated by increased crowding in such households, we implemented binomial regression models with random intercepts per household to account for clustering, and we compared several alternative models. First, we compared a baseline model including a binary variable for the presence of children in the household (Table 2, Model 2) to an alternative model including the total number of residents in the household (Table 2, Model 3). Model 3 demonstrated a better fit based on the AIC. A mediation analysis to test whether the effect of presence of children is mediated by the total number of residents showed a statistically significant indirect effect (p < 0.01), accounting for an estimated 80% of the total effect (Table 3).

thumbnail
Table 3. Mediation analysis for the effect of presence of children in the household.

https://doi.org/10.1371/journal.pmed.1004093.t003

Poverty and unemployment among women

Women were more likely to be unemployed than men (61.7% [95% CI 58.4% to 64.9%] versus 35.5% [95% CI 31.6% to 39.6%]) and had lower income per capita in their households (Fig 3A) regardless of employment status (median [IQR] 2.67 [1.53 to 6.67] versus 6.67 [3.25 to 7.33] USD/day among employed adults; 0.67 [0 to 2.32] versus 0.94 [0 to 3.73] USD/day among unemployed adults). After accounting for income and employment, seroprevalence remained higher among women compared to men (Fig 3B). Women who were unemployed and had a household per capita income below 1.25 USD/day were significantly more likely to be seropositive compared to men with the same employment and income status (Fig 3B).

thumbnail
Fig 3. Socioeconomic vulnerability among women.

(A) Household income (per capita) by employment status and gender. (B) Seroprevalence by household income (per capita), employment status, and gender. Asterisks indicate statistically significant differences (2-tailed t test, Bonferroni-adjusted p < 0.05: *; <0.01: **; <0.001: ***; α = 0.0125 in panels (A and B)). USD, US Dollar.

https://doi.org/10.1371/journal.pmed.1004093.g003

Sensitivity analyses

In additional analyses considering data only from households in which all residents provided a serum sample (Figs D–F in S1 Appendix), using a higher cutoff for seropositivity (Table F in S1 Appendix), adding additional age strata (<13 and 13 to 17; Table G in S1 Appendix), and using multiple imputation to account for missing data (Table H in S1 Appendix), our findings of higher seroprevalence among children and women, and in households with children, remained unchanged.

Discussion

From the early days of the COVID-19 pandemic, there was recognition that the fragile structural and social environment of urban slums constitutes an important yet poorly understood risk [2,22]. Although studies have described socioeconomic disparities in COVID-19 risk and outcomes [23,24], few have focused on the particular risk of urban slums. In this community-based study conducted in the city of Salvador, Brazil, we found that nearly half of residents in an urban slum had evidence of SARS-CoV-2 infection after the first wave of the epidemic in 2020 and before the peak of the second wave. In contrast, cross-sectional surveys conducted among blood donors in the states of São Paulo and Rio Grande do Sul estimated 10% to 30% seroprevalence in February 2021, when our data collection ended [25,26]. This finding is consistent with studies in other settings that reported higher seroprevalence in slums than in non-slum settings [4,27], highlighting the increased vulnerability of socioeconomically deprived communities.

We were able to collect detailed demographic and socioeconomic data at both individual and household levels and overcome the limitations of previous studies that investigated COVID-19 risk in slum compared to non-slum areas, but did not examine the gradients of risk within a slum community [27,28]. Our findings suggest that even within an overall socioeconomically deprived environment, there is a gradient of risk associated with sociodemographic characteristics and household composition.

We found that children in this urban slum setting had high SARS-CoV-2 seroprevalence, significantly greater than observed in adults, which sharply contrasts with patterns of transmission in high-income countries and urban populations within these countries. Most studies to date have reported lower or similar seroprevalence of COVID-19 among children compared to adults during the early phase of the pandemic [29]. Serosurveys relying on residual clinical samples have reported higher prevalence among children, but may not be reflective of the general population of children who do not regularly undergo blood draws [3032]. The community-based design of our study allows for better comparability of seroprevalence between children and adults. Prior studies of respiratory viruses such as influenza showed that school-aged children are reservoirs of transmission [33,34]. We found that adults aged 30 to 44 and 60 years or more were more likely to be SARS-CoV-2 seropositive if they lived with children, suggesting that the multigenerational composition of urban slum households contributes to infection risk in specific adult groups (likely parents and grandparents). However, we were unable due to the cross-sectional design to determine whether children were more likely to be the index case within households.

Although SARS-CoV-2 seropositivity was associated with larger household size, the OR for seropositivity among children remained statistically significant in models that included the total number of household residents, suggesting that the high seropositivity in children cannot be exclusively attributed to household size. Schools in Salvador closed in-person instruction for a prolonged period from March 2020 to May 2021 [35]. Yet, children may have continued to socialize in similarly assortative patterns within their urban slum community (e.g., contact with other children in neighboring houses). The combination of school closures and the lack of safe childcare options may have resulted in higher exposure to SARS-CoV-2 in high-risk urban slum environments, as suggested by the high seroprevalence observed in this study.

We found that women in this urban slum community had significantly higher risk compared to men. Although there is evidence for sex differences in the immune response to SARS-CoV-2 infection and disease severity [36], serological surveys have generally found similar or lower prevalence among women compared to men [37]. Thus, the gender difference in risk observed in our study was likely driven by social rather than biological determinants. Interestingly, higher seroprevalence among women has also been reported in other urban slum settings: two serosurveys conducted in urban slums in Mumbai and Bangalore, India reported a higher seroprevalence among women than men, but did not investigate potential mediators of this effect [4,28]. We found that women who were unemployed and had the lowest household incomes were significantly more likely to be seropositive for SARS-CoV-2. Thus, the disparities between slum and non-slum areas are compounded by additional disparities within slum populations resulting in exacerbated SARS-CoV-2 infection risk for the poorest women.

A limitation of this study is that our data do not allow for identification of time of infection nor of primary cases within households, such that we were unable to identify which household members were first to be infected and estimate what proportion of SARS-CoV-2 transmission occurred within households. Although waning of antibody titers may result in missed identification of individuals with a prior infection, serological surveys offer important alternative and complementary data on community transmission that captures asymptomatic infections with minimal bias from differences in test-seeking and access. Our observational design does not allow for a complete decomposition of the complex interactions between gender, employment, income, household structure, and other unmeasured variables: households with children are larger, and larger households have lower per capita income, such that regression model estimates are not truly independent. Nevertheless, our data highlight the need for targeted interventions (e.g., local, cost-free access to prevention and treatment) that address the risk experienced by the most vulnerable segments of slum communities, such as women who are unemployed, and the poorest households.

Potential sources of bias include selection bias as participants in the study may differ from residents who chose not to participate, although our post-stratified estimates of seroprevalence among all eligible residents were similar to estimates among study participants. Ascertainment and recall bias cannot be excluded, as many of the exposure variables were participant-reported. Although survival bias may result in lower estimates of seroprevalence, mortality was relatively low in Salvador (2.5% in February 2021) [38] and in our study population. We did not have complete serological data for all household residents, but in sensitivity analyses using only data from households with serological results for all residents, our findings remained consistent. While the survey was initiated during a period of lower incidence following the first wave, an unforeseen second wave led to rising incidence during the period of data collection. Our seroprevalence estimates may thus reflect infection risk attributable to both the first and the second waves of transmission. Finally, this study was initiated relatively early in the pandemic. With the emergence of multiple variants of concern causing rapidly successive incidence surges and the deployment of vaccines, more sophisticated methods will be needed to infer epidemic trends from serological surveillance data.

Conclusions

Our study provides key insights into the gradient of SARS-CoV-2 infection risk within the deprived environment of urban slums, leveraging a large community-based cohort with detailed demographic and socioeconomic data at both individual and household levels. While the specific microenvironment of each community is unique, Pau da Lima shares features with urban slum communities in general: vulnerability to COVID-19 derives from the physical environment (construction quality, crowding, poor ventilation, poor access to sanitation facilities), as well as the social environment (financial precarity, mobility, social contact patterns) [39,40]. For example, slum residents are less able to isolate as they must travel to work and maintain an income and depend on often crowded and poorly ventilated public transportation to places of work typically located far from slum areas [41].

As has become evident, effective responses to the COVID-19 pandemic must include not only biomedical interventions but also the deployment of social support systems to mitigate the profound disruptions caused by the disease itself and control measures [42,43]. Participants in our study reported high adherence to hand hygiene and mask use but less frequent social and physical distancing, possibly because such measures are less feasible and effective in the crowded environment of slums. Moreover, given that the structural factors (poverty, crowding) that we have identified may not be readily modified in the short term, implementing and guaranteeing access to interventions that can mitigate the resultant risk (e.g., vaccination, therapeutic treatment, ventilation in public spaces) is crucial to achieve an equitable pandemic response.

Supporting information

S1 STROBE Checklist. Checklist of items that should be included in reports of cross-sectional studies.

https://doi.org/10.1371/journal.pmed.1004093.s001

(DOC)

S1 Appendix. Additional details of methods and sensitivity analyses.

Table A in S1 Appendix. Demographic characteristics of eligible residents and study participants. Table B in S1 Appendix. Specificity associated with model-derived seropositivity thresholds. Table C in S1 Appendix. Adjusted seroprevalence estimates. Table D in S1 Appendix. Univariable logistic regression analyses of individual and household characteristics associated with seropositivity. Table E in S1 Appendix. Adherence to non-pharmaceutical interventions. Table F in S1 Appendix. Sensitivity analysis with higher seropositivity threshold. Table G in S1 Appendix. Sensitivity analysis with different age categories. Table H in S1 Appendix. Multivariable analyses with multiple imputation. Fig A in S1 Appendix. Study eligibility and recruitment flowchart. Fig B in S1 Appendix. Observed and fitted distributions of normalized OD values. Fig C in S1 Appendix. Household composition. Fig D in S1 Appendix. Comparison of households with complete serological data and overall study population. Fig E in S1 Appendix. Sensitivity analysis on effect of age among households with complete serological data. Fig F in S1 Appendix. Sensitivity analysis on the effects of gender, income, and household composition among households with complete serological data.

https://doi.org/10.1371/journal.pmed.1004093.s002

(PDF)

Acknowledgments

We would like to thank the members of the Pau da Lima community in Salvador, Brazil.

References

  1. 1. United Nations Human Settlements Program (UN-Habitat). World cities report 2020: The value of sustainable urbanization. Nairobi, Kenya; 2020. [cited 2021 Aug 3] Available from: https://unhabitat.org/World%20Cities%20Report%202020.
  2. 2. Corburn J, Vlahov D, Mberu B, Riley L, Caiaffa WT, Rashid SF, et al. Slum Health: Arresting COVID-19 and Improving Well-Being in Urban Informal Settlements. J Urban Health. 2020;97:348–357. pmid:32333243
  3. 3. Rocha R, Atun R, Massuda A, Rache B, Spinola P, Nunes L, et al. Effect of socioeconomic inequalities and vulnerabilities on health-system preparedness and response to COVID-19 in Brazil: a comprehensive analysis. Lancet Glob Health. 2021;9:e782–e792. pmid:33857500
  4. 4. Malani A, Shah D, Kang G, Lobo GN, Shastri J, Mohanan M, et al. Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India. Lancet Glob Health. 2021;9:e110–e111. pmid:33197394
  5. 5. Reis RB, Ribeiro GS, Felzemburgh RDM, Santana FS, Mohr S, Melendez AXTO, et al. Impact of Environment and Social Gradient on Leptospira Infection in Urban Slums. Gurtler RE, editor. PLoS Negl Trop Dis. 2008;2:e228. pmid:18431445
  6. 6. Gaskin DJ, Thorpe RJ, McGinty EE, Bower K, Rohde C, Young JH, et al. Disparities in Diabetes: The Nexus of Race, Poverty, and Place. Am J Public Health. 2014;104:2147–2155. pmid:24228660
  7. 7. Brazil Ministry of Health. Painel Coronavírus [Internet]. 2022 [cited 2022 Aug 6]. Available from: https://covid.saude.gov.br/.
  8. 8. Hagan JE, Moraga P, Costa F, Capian N, Ribeiro GS, Wunder EAJ, et al. Spatiotemporal Determinants of Urban Leptospirosis Transmission: Four-Year Prospective Cohort Study of Slum Residents in Brazil. PLoS Negl Trop Dis. 2016;10:e0004275. pmid:26771379
  9. 9. Kikuti M, Cunha GM, Paploski IAD, Kasper AM, Silva MMO, Tavares AS, et al. Spatial Distribution of Dengue in a Brazilian Urban Slum Setting: Role of Socioeconomic Gradient in Disease Risk. PLoS Negl Trop Dis. 2015;9:e0003937. pmid:26196686
  10. 10. Anjos RO, Mugabe VA, Moreira PSS, Carvalho CX, Portilho MM, Khouri R, et al. Transmission of Chikungunya Virus in an Urban Slum, Brazil Emerg Infect Dis. 2020;26:1364–1373. pmid:32568045
  11. 11. Rodriguez-Barraquer I, Costa F, Nascimento EJM, Nery N, Castanha PMS, Sacramento GA, et al. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science. 2019;363:607–610. pmid:30733412
  12. 12. Prefeitura Municipal do Salvador. Plano Plurianual 2018–2021. Salvador, Bahia; 2017 [cited 2022 Jun 28]. Available from: http://casacivil.salvador.ba.gov.br/orcamentos/PPA_2018_2021/include/files/8-%20REGIONALIZA%C7%C3O.pdf.
  13. 13. Instituto Brasileiro de Geografia e Estadística [Brazilian Institute of Geography and Statistics]. Síntese de Indicadores Sociais: Uma análise das condições de vida da população brasileira: 2021. Rio de Janeiro, Rio de Janeiro; 2021 [cited 2022 Aug 6]. Available from: https://biblioteca.ibge.gov.br/visualizacao/livros/liv101892.pdf.
  14. 14. Aguilar Ticona JP, Nery NJ, Victoriano R, Fofana MO, Ribeiro GS, Giorgi E, et al. Willingness to Get the COVID-19 Vaccine among Residents of Slum Settlements. Vaccines (Basel). 2021;9. pmid:34579188
  15. 15. Aguilar Ticona JP, Baig H, Nery N, Doss-Gollin S, Sacramento GA, Adhikarla H, et al. Risk of Sexually Transmitted Zika Virus in a Cohort of Economically Disadvantaged Urban Residents. J Infect Dis. 2021;224:860–864. pmid:33395487
  16. 16. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–381. pmid:18929686
  17. 17. Euroimmun AG. Anti-SARS-CoV-2 S1 Curve ELISA (IgG) Instructions for use. 2022 [cited 2022 May 2]. Available from: https://www.fda.gov/media/152747/download.
  18. 18. Hitchings MDT, Patel EU, Khan R, Srikrishnan AK, Anderson M, Kumar KS, et al. A mixture model to estimate SARS-CoV-2 seroprevalence in Chennai, India. Epidemiology. 2022.
  19. 19. Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study. Lancet. 2020;396:313–319. pmid:32534626
  20. 20. Tingley D, Yamamoto T, Hirose K, Keele L, Imai K. mediation: R Package for Causal Mediation Analysis. J Stat Softw. 2014;59.
  21. 21. R Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Available from: https://www.R-project.org/.
  22. 22. Pereira RJ, do Nascimento GNL, Gratão LHA, Pimenta RS. The risk of COVID-19 transmission in favelas and slums in Brazil. Public Health. 2020;183:42–43. pmid:32422438
  23. 23. Castro RR, Santos RSC, Sousa GJB, Pinheiro YT, Martins RRIM, Pereira MLD, et al. Spatial dynamics of the COVID-19 pandemic in Brazil. Epidemiol Infect. 2021;149:e60. pmid:33629938
  24. 24. Mena GE, Martinez PP, Mahmud AS, Marquet PA, Buckee CO, Santillana M. Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile. Science. 2021;372:eabg5298. pmid:33906968
  25. 25. Moya Rios do Vale N, Roche Moreira Latini F, Prisco Arnoni C, Martins Parreira R, Batista Castelo Girão MJ, Pereira Cortez AJ, et al. Increasing rate of anti-SARS-CoV-2 antibodies between the first and second waves of COVID-19 in São Paulo, Brazil: A cross-sectional blood donors-based study. Clinics. 2022;77:100016. pmid:35272203
  26. 26. Barros AJD, Victora CG, Menezes AMB, Horta BL, Barros FC, Hartwig FP, et al. Population-level seropositivity trend for SARS-Cov-2 in Rio Grande do Sul, Brazil. Rev Saúde Pública. 2021;55:78. pmid:34816981
  27. 27. Macchia A, Ferrante D, Battistella G, Mariani J, González Bernaldo de Quirós F. COVID-19 among the inhabitants of the slums in the city of Buenos Aires: a population-based study. BMJ Open. 2021;11:e044592. pmid:33472790
  28. 28. George CE, Inbaraj LR, Chandrasingh S, de Witte LP. High seroprevalence of COVID-19 infection in a large slum in South India; what does it tell us about managing a pandemic and beyond? Epidemiol Infect. 2021;149:e39. pmid:33536108
  29. 29. Viner RM, Mytton OT, Bonell C, Melendez-Torres GJ, Ward J, Hudson L, et al. Susceptibility to SARS-CoV-2 infection among children and adolescents compared with adults: A systematic review and meta-analysis. JAMA Pediatr. 2021;175:143–156. pmid:32975552
  30. 30. Flamand C, Alves Sarmento C, Enfissi A, Bailly S, Beillard E, Gaillet M, et al. Seroprevalence of anti-SARS-CoV-2 IgG at the first epidemic peak in French Guiana, July 2020. Bowman N, editor. PLoS Negl Trop Dis. 2021;15:e0009945. pmid:34767549
  31. 31. Reicher S, Ratzon R, Ben-Sahar S, Hermoni-Alon S, Mossinson D, Shenhar Y, et al. Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel. Eur J Epidemiol. 2021;36:727–734. pmid:33884542
  32. 32. Bajema KL, Wiegand RE, Cuffe K, Patel SV, Iachan R, Lim T, et al. Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020. JAMA Intern Med. 2021;181:450. pmid:33231628
  33. 33. Read JM, Zimmer S, Vukotich C, Schweizer ML, Galloway D, Lingle C, et al. Influenza and other respiratory viral infections associated with absence from school among schoolchildren in Pittsburgh, Pennsylvania, USA: a cohort study. BMC Infect Dis. 2021;21:291. pmid:33752625
  34. 34. Cauchemez S, Bhattarai A, Marchbanks TL, Fagan RP, Ostroff S, Ferguson NM, et al. Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza. Proc Natl Acad Sci U S A. 2011;108:2825–2830. pmid:21282645
  35. 35. Valverde F. Prefeitura apresenta protocolos de retomada da educação em Salvador. A Tarde. 2021 [cited 2021 Oct 5]. Available from: https://atarde.com.br/bahia/bahiasalvador/prefeitura-apresenta-protocolos-de-retomada-da-educacao-em-salvador-1155094.
  36. 36. Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588:315–320. pmid:32846427
  37. 37. Lai C-C, Wang J-H, Hsueh P-R. Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review. Int J Infect Dis. 2020;101:314–322. pmid:33045429
  38. 38. Prefeitura Municipal do Salvador. Indicadores COVID-19 [Internet]. [cited 2022 Jun 29] Available from: http://www.saude.salvador.ba.gov.br/covid/indicadorescovid/.
  39. 39. Lilford RJ, Oyebode O, Satterthwaite D, Melendez-Torres GJ, Chen Y-F, Mberu B, et al. Improving the health and welfare of people who live in slums. Lancet. 2017;389:559–570. pmid:27760702
  40. 40. Buckley RM. Targeting the World’s Slums as Fat Tails in the Distribution of COVID-19 Cases. J Urban Health. 2020;97:358–364. pmid:32488763
  41. 41. Pinchoff J, Kraus-Perrotta C, Austrian K, Tidwell JB, Abuya T, Mwanga D, et al. Mobility Patterns During COVID-19 Travel Restrictions in Nairobi Urban Informal Settlements: Who Is Leaving Home and Why. J Urban Health. 2021;98:211–221. pmid:33533010
  42. 42. Clapp J, Calvo-Friedman A, Cameron S, Kramer N, Kumar SL, Foote E, et al. The COVID-19 shadow pandemic: Meeting social needs for a city in lockdown. Health Aff. 2020;39:1592–1596. pmid:32673101
  43. 43. Bariola N, Collins C. The gendered politics of pandemic relief: Labor and family policies in Denmark, Germany, and the United States during COVID-19. Am Behav Sci. 2021;000276422110031.